Daser A, Meissner N, Herz U, Renz H
Virchow Klinikum of the Humboldt University, Berlin, Germany.
Curr Opin Immunol. 1995 Dec;7(6):762-70. doi: 10.1016/0952-7915(95)80045-x.
Allergic sensitization and the development of effector functions are controlled by IL-4-secreting and IL-5-secreting type 2 T cells. Recent studies have provided new insights into the events triggering the development of type 1 and type 2 T cells, the discrimination of type 1 and type 2 effector T cells from various T-cell subsets, and the improvement of established and new therapeutic strategies, which are aimed at modulating such T-cell functions in the allergic patient.
过敏致敏作用和效应功能的发展由分泌白细胞介素-4和分泌白细胞介素-5的2型T细胞控制。最近的研究为触发1型和2型T细胞发育的事件、从各种T细胞亚群中区分1型和2型效应T细胞以及改进既定的和新的治疗策略提供了新的见解,这些治疗策略旨在调节过敏患者的此类T细胞功能。